Oral atenolol versus propranolol in the treatment of infantile hemangioma: A systematic review and meta-analysis

Background: Infantile hemangioma (IH) is the most common benign vascular tumor of infancy. Propranolol is considered first-line therapy for IH. However, it is associated with side effects. Therefore, there was a need for alternative therapy. Atenolol, a selective b1-blocker may be free from such sid...

Descripción completa

Detalles Bibliográficos

Autores principales:	Swapnil Annasaheb Pattanshetti, Vidya M Mahalmani, Phulen Sarma, Hardeep Kaur, Md Mokkaram Ali, Muneer Abas Malik, Nitin James Peters, Manisha Prajapat, Subodh Kumar, Bikash Medhi, Ram Samujh
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2022-01-01
Colección:	Journal of Indian Association of Pediatric Surgeons
Materias:	atenolol beta-blocker infantile hemangioma propranolol
Acceso en línea:	http://www.jiaps.com/article.asp?issn=0971-9261;year=2022;volume=27;issue=3;spage=279;epage=286;aulast=Pattanshetti
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!